Eye Cancer clinical trials

Explore recruiting eye cancer clinical trials.

Recruiting eye cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Eye Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A RANDOMIZED, PHASE 3, OPEN-LABEL STUDY OF NEOADJUVANT DAROVASERTIB IN SUBJECTS WITH PRIMARY NON-METASTATIC UVEAL MELANOMA (OptimUM-10)

France, Spain, Poland, Italy, Czechia, Belgium +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

As Phase I/II, multi-center, open label study of DYP688 in patients with metastatic uveal melanoma (MUM) and other GNAQ/11 mutant melanomas

Germany, Spain, France, Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Eye Cancer trials by city

Eye Cancer in Toronto Eye Cancer in Vancouver Eye Cancer in Montreal Eye Cancer in Calgary Eye Cancer in Edmonton Eye Cancer in Ottawa Eye Cancer in Winnipeg Eye Cancer in Quebec City Eye Cancer in Hamilton Eye Cancer in Kitchener Eye Cancer in London Eye Cancer in Halifax Eye Cancer in New York Eye Cancer in Los Angeles Eye Cancer in Chicago Eye Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease